Selecting the Best Prostate Cancer Surgeons and Hospitals in India for Canadian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 14-08-2026

In 24 years of guiding international patients into Indian hospitals, this figure is genuinely valuable precisely because it's live, government-published data, updated monthly, not a historical average that may no longer reflect current reality. Nova Scotia's Patient Access Registry shows exactly what current patients are experiencing right now, and it confirms that the genuine total journey, from first referral through to surgery, runs considerably longer than any single benchmark figure alone would suggest.

Healing Journeys of Canadian Patients

Canadian Patients Share Their Experience

Key Takeaways

• The guide highlights 125 days as the current total wait for prostate cancer surgery in Nova Scotia, including 22 days for specialist consultation and 103 additional days to surgery.
• The page 2 chart shows a documented seasonal reduction in robotic prostatectomy capacity, with July surgical volume averaging 7.1 cases per month versus 10.9 overall, a 35% reduction, while booking demand remained steady or increased.
• India is presented as a considered alternative because leading urologic oncology centres perform robotic-assisted radical prostatectomy throughout the year, with fellowship-trained specialists, English-language care and JCI/NABH-accredited hospitals. Treatment can typically begin within 2–3 weeks of the first consultation.
• The selection framework gives 55% weighting to the surgeon and 45% to the hospital, assessing robotic prostatectomy volume, urologic oncology training, surgeon involvement, oncological outcomes, continence and potency outcomes, robotic capacity, accreditation and postoperative support.
• The page 4 qualification table identifies MS General Surgery followed by MCh Urology as the relevant specialist pathway. Warning signs include pricing before reviewing PSA and biopsy results, vague robotic surgery volume, no discussion of functional outcomes and no structured postoperative support.
• The page 4 cost chart gives illustrative costs of approximately C$8,000 in India, C$15,000 in Thailand, C$24,000 in Singapore, C$35,000 in Canada and C$80,000 in the United States for robotic-assisted radical prostatectomy. Actual costs vary by technique and disease stage, so an itemised quotation should be obtained.

Quick Facts

Treatment

Robotic-Assisted Radical Prostatectomy

Patients

Canadian Patients

Key Specialist

Urologic Oncologist / Urologist

Selection Weighting

55% surgeon / 45% hospital

Base Qualification

MS General Surgery

Advanced Qualification

MCh Urology – 3 further years

Key Expertise

Robotic prostatectomy-specific surgical volume

Outcome Check

Cancer control, continence and potency outcomes

Technology

Robotic-assisted prostatectomy

Hospital Check

Dedicated robotic surgery programme

Accreditation

JCI / NABH verification

India Cost

Approximately C$8,000

Canada Cost

Approximately C$35,000

US Cost

Approximately C$80,000

Pre-Travel Records

PSA history, biopsy results and staging imaging

Treatment Timeline

Typically 2–3 weeks from first consultation

Recovery Support

Structured continence and sexual-health support

Follow-Up

Canadian urologist with ongoing PSA monitoring

Key Warning

Avoid centres that quote a price before reviewing PSA and biopsy results

Decision Principle

Prioritise genuine robotic prostatectomy volume, cancer outcomes and functional recovery support.

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

For Canadian patients whose urologic oncologist has confirmed that surgery is the appropriate treatment, the guide recommends comparing robotic prostatectomy-specific surgical volume, urologic oncology training, cancer-control outcomes, continence and potency outcomes, hospital capacity and postoperative support rather than choosing a centre on cost alone. Long-term PSA monitoring should also be arranged with the Canadian urologist before returning home.

Prostate cancer is the most commonly diagnosed cancer in Canadian men, and many are treated well through the public system. This guide exists for a narrower, specific group: patients whose urologic oncologist has confirmed surgery is the right path, weighing where and when that surgery should happen.

For patients facing this genuine, currently-documented wait, the case for looking seriously at India is a strong one: internationally accredited hospitals, fellowship-trained urologic oncologists operating at genuinely high, year-round volume, robotic-assisted surgical technique in routine daily use, and treatment that can typically begin within two to three weeks of your first consultation, all at a fraction of the equivalent Canadian private cost. This isn't a fallback option; for patients who understand exactly what the current data shows, it's a considered, well-evidenced alternative worth exploring seriously.

A genuine, calendar-driven surgical slowdown, not a clinical one

Get your full PSA history, biopsy results and staging imaging together before your first overseas conversation. This finding, from a rigorous 10-year study of two high-volume Canadian academic urology centres, deserves genuine attention because of what it reveals: patients booking surgery in summer months face a real, measurable reduction in surgical capacity that has nothing to do with their own cancer or clinical urgency, and everything to do with when hospital staff take vacation. The researchers found booking volumes remained steady or even increased during these same months, meaning demand didn't fall; capacity simply did.

This matters directly for how you should think about timing any Canadian surgical booking. If your consultation or diagnosis happens to fall in late spring or early summer, understanding that your genuine wait for surgery itself may be longer than the annual average, purely due to this seasonal pattern, is a genuinely useful piece of context most patients are never given. Separate research from the same group examining biochemical recurrence, the return of detectable cancer markers after surgery, specifically explored whether the length of the surgical wait itself affects outcomes, precisely because a prostate cancer diagnosis creates genuine, understandable pressure to understand whether any delay carries real cancer risk, not just a scheduling inconvenience.

This body of Canadian research reflects a genuinely more sophisticated understanding of prostate cancer surgery timing than many patients receive at diagnosis. It's not simply a question of “sooner is always better”; it's a question of understanding your own specific risk profile, and recognising that the wait you experience may be shaped as much by which month you happen to be booked in as by any clinical urgency in your case.

Why India specifically, not just “overseas”

This is worth spelling out plainly, because “medical travel” can sound vague until you see what it actually means in practice. India's leading urologic oncology centres perform a volume of robotic-assisted radical prostatectomies, consistently across every month of the year, that reflects the scale of the population they serve, a depth of experience genuinely difficult to match within a Canadian system where surgical capacity itself is documented to fluctuate with the seasons. This is not a compromise reached for cost and speed; for the right case, it is comparable or genuinely greater depth of specific surgical experience, delivered without the calendar-driven capacity gaps Canadian research has itself documented.

Robotic-assisted radical prostatectomy is established, routine daily practice at India's leading centres, performed by surgeons who maintain genuine, consistent case volume year-round. Every consultation, medical record, consent discussion and follow-up letter happens in English, conducted by specialists who trained in programs recognised internationally, many with fellowship experience in Canada, the US or the UK themselves. Leading hospitals hold Joint Commission International accreditation, the same standard used to accredit hospitals across the United States, alongside India's own NABH certification. Put together, this is genuinely comparable urologic oncology care, available in weeks rather than months, at a fraction of the price.

Ten weighted criteria, out of 100

The same weighting that applies across this series applies here: the surgeon carries 55 points, the hospital 45. Part one, judging the surgeon: genuine volume in robotic prostatectomy specifically, fellowship training in urologic oncology, whether the surgeon personally operates, and candid continence and potency outcome data alongside oncological outcomes.

Part two, judging the hospital: a dedicated robotic surgery programme with consistent, year-round scheduling capacity, verified international accreditation, structured post-operative continence and sexual health support, and a complete operative record your Canadian urologist can use.

Four Signals That Should Make You Pause

• A price quoted before your PSA and biopsy results have been reviewed. Nobody can meaningfully assess your case, or price the surgery, without seeing your specific results.
• Vagueness about the surgeon's volume in robotic prostatectomy specifically. General reassurance about “extensive urology experience” is not an answer.
• No discussion of continence and potency outcomes alongside cancer control. A responsible surgeon addresses all three, not oncological outcome alone.
• No structured post-operative support plan. Ask specifically what continence and recovery support is included.

Canada-specific considerations most patients miss

Ask your urologist directly about seasonal scheduling patterns at your specific hospital. Given the documented summer slowdown, this genuinely practical question could shape your own timeline expectations considerably.

Tell your Canadian urology team early, not after the fact. Most are more sympathetic to a second opinion than patients expect.

Arrange your ongoing PSA monitoring before you leave. Confirm your Canadian urologist is willing to manage long-term follow-up based on overseas surgical findings.

The Questions, in the Order You Should Ask Them

A closing word

Canada's own currently-tracked data confirms a genuine, real total wait for prostate cancer surgery running well beyond a single benchmark figure, compounded by a documented, calendar-driven summer slowdown that has nothing to do with clinical need. For patients facing that reality, the case for India is genuinely strong, not a fallback option: internationally accredited urologic oncology centres with deep, consistent, year-round surgical volume, and treatment that can typically begin within two to three weeks, at a fraction of the equivalent Canadian private cost.

In 24 years of guiding patients through exactly this decision, the pattern is consistent: those who look closely at what India's leading prostate cancer centres actually offer, rather than assuming distance means compromise, generally come away reassured rather than anxious. Weight genuine surgical volume heavily, ask about continence and potency outcomes alongside cancer control, and travel with a written, itemised quote in hand.

If you would like a second opinion on your case, send the details and I will look at it properly.

Frequently Asked Questions by Canadians about Prostate Cancer Surgeons and Hospitals in India

What is the current prostate cancer surgery wait highlighted in the guide?

The guide cites 125 days as the total current wait in Nova Scotia, comprising 22 days for specialist consultation and 103 additional days to surgery.

Does the guide identify a seasonal effect on prostate cancer surgery?

Yes. The cited 10-year study found July robotic prostatectomy volume averaged 7.1 cases per month versus 10.9 overall, representing a 35% reduction in surgical capacity.

Which specialist qualification should I look for?

The guide identifies MS General Surgery followed by MCh Urology, with the latter providing dedicated further training in urological and robotic surgery.

How important is robotic prostatectomy-specific volume?

It is a key selection criterion. Patients should ask for the surgeon's actual robotic prostatectomy volume, rather than accepting general statements about extensive urology experience.

Which outcomes should the surgeon discuss?

The guide recommends discussing cancer-control outcomes alongside continence and potency outcomes, rather than focusing only on cancer treatment.

How much does robotic prostatectomy cost in India?

The guide gives an illustrative cost of approximately C$8,000 in India, compared with C$35,000 in Canada and C$80,000 in the US.

What should I send before travelling?

Prepare your full PSA history, biopsy results and staging imaging before the first overseas consultation.

What are the main warning signs when choosing a centre?

The guide identifies early pricing before reviewing results, vague robotic prostatectomy volume, no discussion of continence and potency outcomes, and no structured postoperative support plan.

What should I ask the surgeon?

Ask about their specific robotic prostatectomy volume, whether they will personally operate, their continence and potency results, and their oncological outcomes for your disease stage.

What should I arrange before returning to Canada?

Arrange ongoing PSA monitoring with your Canadian urologist and ensure the complete operative record is transferred for long-term follow-up.

Sources

• Nova Scotia Wait Time Information, Prostate Cancer Surgery, February–April 2026 — waittimes.novascotia.ca
• Zorn et al., Impact of Surgical Wait Times During Summer Months on Oncological Outcomes Following RARP, World Journal of Urology, 2020 — link.springer.com
• Canadian Institute for Health Information, Wait Times for Priority Procedures in Canada, 2025 — cihi.ca
• National Medical Commission — nmc.org.in
• National Accreditation Board for Hospitals & Healthcare Providers — nabh.co

Page Summary

This guide helps Canadian patients compare prostate cancer surgeons and hospitals in India, focusing on robotic prostatectomy-specific expertise, oncological and functional outcomes, hospital accreditation, postoperative support, cost and Canadian follow-up; it highlights a 125-day current total surgical wait in Nova Scotia and a documented 35% reduction in July robotic prostatectomy volume at two Canadian academic centres, while presenting India as an option with consistent year-round robotic surgery capacity and treatment that can typically begin within 2–3 weeks, with illustrative costs of approximately C$8,000 in India, C$35,000 in Canada and C$80,000 in the US.

Citation Block

Field	Information
Topic	Best Prostate Cancer Surgeons & Hospitals in India for Canadian Patients
Treatment	Robotic-Assisted Radical Prostatectomy
Patients	Canadian Patients
Specialist	Urologic Oncologist / Urologist
Selection Weighting	55% surgeon / 45% hospital
Key Qualification	MS General Surgery + MCh Urology
Experience Check	Robotic prostatectomy-specific surgical volume
Outcome Check	Oncological, continence & potency outcomes
Surgeon Check	Whether the named surgeon personally operates
Hospital Check	Consistent year-round robotic surgery capacity
Support Check	Structured continence & sexual-health support
Accreditation	JCI / NABH verification
India Cost	~C$8,000
Canada Cost	~C$35,000
US Cost	~C$80,000
Records Required	PSA history, biopsy results & staging imaging
Wait-Time Reference	125 days total in Nova Scotia
Seasonal Finding	July robotic prostatectomy volume 35% below cohort average
Follow-Up	Canadian urologist & ongoing PSA monitoring
Patient Planning	Discuss seasonal scheduling patterns with the Canadian urologist
Second Opinion	Share complete PSA, biopsy and staging information
Warning Signs	Early pricing, vague robotic volume, no functional outcome discussion, no postoperative support
Patient Pathway	PSA/biopsy/staging → video consultation → itemised quote → travel/pre-op workup → robotic surgery → team review → records to Canada
Key Decision	Prioritise procedure-specific volume, oncological outcomes and continence/potency support